Early Referral,Living Donation,and Preemptive Kidney Transplant |
| |
Affiliation: | 1. Nephrology, Mid-Atlantic Permanente Medical Group, McLean, Virginia;2. Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland;3. KP National Transplant Services, Central East Hub, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland |
| |
Abstract: | BackgroundPreemptive kidney transplant (PKT) is recognized as the most beneficial and cost-effective form of renal replacement therapy among patients with end-stage renal disease. Despite optimal outcomes and improved quality of life associated with PKT, its use as a first renal replacement therapy remains low among patients with end-stage renal disease. The goal of this retrospective cohort study was to compare, among adult kidney transplant recipients, characteristics across PKT status.MethodsWe compared the characteristics of patients who did and did not have a PKT over 5 years, from 2010 to 2014, using the electronic health records of Kaiser Permanente Mid-Atlantic States.ResultsA total of 233 patients received a kidney-alone transplant, and, of these, 44 patients (19%) were PKT and 189 patients (81%) were non-PKT. Of the patients in the PKT group, 43% received a kidney from a deceased donor. PKT recipients were more often White, had polycystic kidney disease or glomerulonephritis, received a living donor organ, and were transplanted at certain transplant centers. Estimated glomerular filtration rate on listing for those who received a deceased donor transplant was higher in PKT than non-PKT patients listed pre-dialysis.ConclusionsPKT was associated with having a living kidney donor and with having a higher estimated glomerular filtration rate at listing for deceased donor recipients. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|